Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Receivables (2024 - 2025)

Historic Receivables for Stoke Therapeutics (STOK) over the last 2 years, with Q3 2025 value amounting to $10.8 million.

  • Stoke Therapeutics' Receivables changed N/A to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Stoke Therapeutics' Receivables stood at $10.8 million.
  • In the past 5 years, Stoke Therapeutics' Receivables registered a high of $10.8 million during Q3 2025, and its lowest value of $2.4 million during Q4 2024.